O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
NCNA
426
NuCana
NCNA
$5.51M
|
LG
Leland Gershell
| $2.89 | $5,000 |
172,910%
upside
| Outperform |
3 Sep ‘24
1 year ago |
|
427
MannKind Corp
MNKD
$1.71B
|
SL
Steven Lichtman
| $5.57 | $12 |
115%
upside
| Outperform |
28 Aug ‘24
1 year ago |
|
428
Enovix
ENVX
$2.04B
|
CR
Colin Rusch
| $9.39 | $36 |
283%
upside
| Outperform |
26 Aug ‘24
1 year ago |
|
429
Canadian Solar
CSIQ
$731M
|
CR
Colin Rusch
| $10.92 | $27 |
147%
upside
| Outperform |
23 Aug ‘24
1 year ago |
|
430
Alcon
ALC
$39.5B
|
SL
Steven Lichtman
| $79.97 | $110 |
38%
upside
| Outperform |
22 Aug ‘24
1 year ago |
|
431
Freightos
CRGO
$158M
|
JH
Jason Helfstein
| $3.15 | $3.50 |
11%
upside
| Outperform |
21 Aug ‘24
1 year ago |
|
432
Medtronic
MDT
$119B
|
SL
Steven Lichtman
| $92.99 | $94 |
1%
upside
| Perform |
21 Aug ‘24
1 year ago |
|
433
KALA BIO
KALA
$102M
|
FB
Francois Brisebois
| $14.48 | $15 |
4%
upside
| Outperform |
19 Aug ‘24
1 year ago |
|
434
DiaMedica Therapeutics
DMAC
$370M
|
FB
Francois Brisebois
| $7.16 | $6 |
16%
downside
| Outperform |
16 Aug ‘24
1 year ago |
|
435
Achieve Life Sciences
ACHV
$150M
|
FB
Francois Brisebois
| $2.93 | $11 |
275%
upside
| Outperform |
15 Aug ‘24
1 year ago |
|
|
CNTA
436
Centessa Pharmaceuticals
CNTA
$2.11B
|
FB
Francois Brisebois
| $18.03 | $14 |
22%
downside
| Outperform |
14 Aug ‘24
1 year ago |
|
437
Gain Therapeutics
GANX
$62.9M
|
JO
Jay Olson
| $1.75 | $8 |
357%
upside
| Outperform |
14 Aug ‘24
1 year ago |
|
438
PACS Group
PACS
$1.76B
|
MW
Michael Wiederhorn
| $11.32 | $40 |
253%
upside
| Outperform |
13 Aug ‘24
1 year ago |
|
439
Protara Therapeutics
TARA
$118M
|
LG
Leland Gershell
| $3.07 | $25 |
714%
upside
| Outperform |
12 Aug ‘24
1 year ago |
|
440
Host Hotels & Resorts
HST
$12B
|
TB
Tyler Batory
| $17.39 | $22 |
27%
upside
| Outperform |
12 Aug ‘24
1 year ago |
|
441
Crinetics Pharmaceuticals
CRNX
$3.31B
|
LG
Leland Gershell
| $35.14 | $73 |
108%
upside
| Outperform |
9 Aug ‘24
1 year ago |
|
442
Backblaze
BLZE
$516M
|
IK
Ittai Kidron
| $9.14 | $10 |
9%
upside
| Outperform |
9 Aug ‘24
1 year ago |
|
443
Pliant Therapeutics
PLRX
$106M
|
JJ
Jeff Jones
| $1.73 | $45 |
2,501%
upside
| Outperform |
8 Aug ‘24
1 year ago |
|
444
Golub Capital BDC
GBDC
$3.93B
|
MP
Mitchel Penn
| $14.81 | $17 |
15%
upside
| Outperform |
7 Aug ‘24
1 year ago |
|
445
Amgen
AMGN
$151B
|
JO
Jay Olson
| $280.19 | $380 |
36%
upside
| Outperform |
7 Aug ‘24
1 year ago |
|
|
NYXH
446
Nyxoah
NYXH
$219M
|
SK
Suraj Kalia
| $5.84 | $13 |
123%
upside
| Outperform |
7 Aug ‘24
1 year ago |
|
447
RxSight
RXST
$366M
|
SL
Steven Lichtman
| $8.94 | $65 |
627%
upside
| Outperform |
6 Aug ‘24
1 year ago |
|
448
DraftKings
DKNG
$23B
|
JK
Jed Kelly
| $46.32 | $55 |
19%
upside
| Outperform |
5 Aug ‘24
1 year ago |
|
449
Neurocrine Biosciences
NBIX
$14.3B
|
JO
Jay Olson
| $143.80 | $219 |
52%
upside
| Outperform |
2 Aug ‘24
1 year ago |
|
450
NerdWallet
NRDS
$850M
|
JK
Jed Kelly
| $11.19 | $18 |
61%
upside
| Outperform |
1 Aug ‘24
1 year ago |
|